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We observed a relative risk of 1.40 (95% confidence interval; 0.86–2.16) for cancers diagnosed under the age 20 in 6192 offspring
of 3431 mothers with a molar pregnancy, indicating it is not a major determinant of childhood cancer.
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The few established causes of childhood cancer, including various
chromosomal anomalies, account for only a small proportion of
the total (Little, 1999). There is, however, evidence that certain
types of childhood cancer originate in utero, although the
underlying biological mechanisms are unclear (Hjalgrim et al,
2002). Maternal characteristics and pregnancy-related events have
therefore been the focus of much research (Roman et al, 2005,
2006). The population-based UK childhood cancer case–control
study (UKCCS, 2000), which examined the obstetric records of
mothers of 2962 childhood cancer cases aged 0–14 years and 4864
matched controls found a statistically significant 2.5-fold increased
childhood cancer risk among mothers with a previous molar
pregnancy (Roman et al, 2005, 2006), suggesting a common
biological process. We therefore conducted a register-based cohort
study in Denmark to examine cancer incidence in the offspring of
women who had been diagnosed as having a molar pregnancy.
MATERIALS AND METHODS
Women who had a molar pregnancy before 2005 were identified
using the Danish National Hospital Register, which contains
information for virtually all non-psychiatric hospital admissions in
Denmark since 1977. Details of children born to these women
were obtained from the National Central Population Register
(CPR), which was established in 1968 with all citizens having
unique personal identification numbers that permit linkage
between registers. The follow-up for cancer incidence, determined
by linking to the National Danish Cancer Registry which has
been in operation since 1943 (Storm et al, 1997), was up to
31 December 2003, the most recent year with complete registra-
tion. Although there were no age restrictions for the linkage, we
decided to include only cancers diagnosed before the age of 20
years in the analyses.
In our analysis, the number of observed cases was compared
with those expected. Expected numbers were determined by
multiplying the number of person-years of cohort members by the
incidence rates of primary cancer in the general population of
Denmark (excluding non-melanoma skin cancer), in sex-specific
5-year age groups and 5-year calendar periods of observa-
tion. Standardised incidence ratios (SIRs) were calculated by
dividing the observed and expected numbers, and exact 95%
confidence limits of the SIRs obtained on the assumption of a
Poisson’s distribution of the observed cancers (Breslow and
Day, 1987). Additional analyses involved restricting the age of
follow-up to 14 years and to children born after their mother’s
molar pregnancy, the latter being primarily for comparison
with previously published data (Roman et al, 2006). Data were
also stratified by sex.
RESULTS
Approximately 1 million women gave birth between 1977 and 2005
from which 3431 women with at least one molar pregnancy were
identified. In total, 7403 children were born to these women, 507
of which were excluded as they were born after 31 December 2003,
the cut-off for linking to the cancer registry. The final cohort of
6896 children was followed up for cancer diagnosis until they
were 20 years old or 31 December 2003, whichever came first,
accruing 83945 person-years under risk. Characteristics of the 20
children who were diagnosed with cancer within this period of
time are shown in Table 1. Non-melanoma skin cancers were
excluded (one case).
The overall SIR based on 20 observed cases vs 14.3 expected was
1.40 (Table 2). When the data were stratified by cancer type no
substantial differences were observed; based on two cases, the SIR
was highest for testicular cancer. Furthermore, there were no
apparent differences between boys (SIR 1.49) or girls (SIR 1.28).
When we restricted the age of diagnosis from 0 to 14 years of age,
we observed an overall SIR of 1.10 (95% confidence interval (CI);
0.58–1.88). To compare our data directly with that previously
published (Roman et al, 2006), we examined cancer risk in
children aged 0–14 years old whose mothers had had a previous
molar pregnancy. We observed SIRs of 0.87 (95% CI: 0.28–2.03; 5
observed/5.8 expected), 1.77 (95% CI: 0.48–4.53; 4/2.3), and 0.00
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y(95% CI: 0.00–5.48; 0/0.7), for all cancers, haematological cancers,
and sarcomas, respectively.
DISCUSSION
We have investigated the relationship between cancers diagnosed
before age 20 years in the offspring of mothers who had at least
one molar pregnancy. For all cancers combined, the estimated
relative risk was 1.40 (95% CI; 0.86–2.16), which although not as
strong as that observed elsewhere (Roman et al, 2006), suggests
this is an area that might benefit from further investigation.
The major strengths of the present study are its population-
based setting and the unbiased and objective identification and
follow-up of cohort members. Indeed, the high-quality, complete
registers that were used for the ascertainment of women with
a molar pregnancy and identification and follow-up of their
offspring for cancer, are an excellent framework for investigating
such a hypothesis. However, although we included the whole
childhood population of Denmark over a period of almost 30 years
we still have a relatively small cohort. Despite this, there
was sufficient statistical power in the study to detect a twofold
risk increase.
Children born after 1977 but whose mothers had had their only
molar pregnancy before this time were not covered in the cohort
but were included in the calculation of the reference rates.
However, since molar pregnancy is a rare event, the number of
such children is a very small proportion of all cancer cases and
therefore the misclassification results in a minor loss of statistical
power rather than a bias in the risk estimation. In contrast to the
UKCCS analyses (Roman et al, 2006) our age range was 0–19 years
and children were included irrespective of whether their mother’s
molar pregnancy was before or after the pregnancy with the index
child – the design of the UK study meant obstetric data were only
available for reproductive events before the birth of the index
child. We did, however, generate risk estimates according to the
UK analytical model for direct comparison.
The association between molar pregnancy and childhood cancer
raises the interesting possibility of a common aetiology. Indeed,
Roman et al (2006) speculated about the potential involvement
of epigenetic mechanisms in relation to both molar pregnancy
and childhood cancer development. Both childhood cancer and
hydatidiform mole (HMs) are rare conditions with around 1 in 600
children likely to develop cancer before they are 15 years old
(Parkin et al, 1998) and HM likely to occur in 1 in 1500
pregnancies in the western world (Altieri et al, 2003). Hydatidi-
form moles generally arise from an abnormal fertilisation and have
been associated with the de-regulation of imprinted genes (Altieri
et al, 2003; Slim and Mehio, 2007). Thus, while epigenetics is not
a new concept with respect to the pathogenesis of HM (Kajii
and Ohama, 1977), for childhood cancer it is a relatively new and
expanding area of research. Loss of imprinting has been implicated
in a number of congenital syndromes, some of which, such as
Beckwith–Wiedemann syndrome, predispose towards certain
childhood cancers (DeBaun and Tucker, 1998). The observation
that childhood cancer can in some cases originate in utero,
combined with the knowledge that many imprinted genes have key
functions in regulating embryonic development (Robertson, 2005)
suggest that it may be similar or even the same epigenetic
predisposition that gives rise to both these conditions.
Recent work has identified NALP7, part of the CATERPILLAR
family of proteins that are involved in cellular inflammatory
responses to infections processes, as the gene causing familial
recurrent HMs (Tschopp et al, 2003; Murdoch et al, 2006). While
its exact role in familial recurrent HMs are unknown, for example
it has no established role in DNA methylation, there have
been several possible biological mechanisms put forward (Slim
and Mehio, 2007). The most interesting of these in relation to
childhood cancer, in particular childhood leukaemia, is the
involvement of NALP7 in the cellular immune response. An
abnormal immune relationship between a mother and a fetus has
been associated with irregular pregnancy outcomes such as HM
and choriocarcinoma (reviewed by Slim and Mehio, 2007). Thus
insight into the aetiology of some childhood cancers may be gained
by investigating the immune function and response of mothers of
children with such conditions.
Importantly from a public health perspective the lack of a strong
association between molar pregnancy and cancer in children and
teenagers confirms the fact that molar pregnancy is not a major
determinant of cancer in the young. However, the issue of overlapping
aetiology remains one to be investigated in future research.
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Table 1 Characteristics of 20 children who developed cancer before the
age of 20 years in a Danish cohort of children born of mothers diagnosed
with a molar pregnancy
Diagnostic
main group Cancer diagnosis
Age at
diagnosis
(years) Gender
a
Haematological Acute lymphoblastic leukaemia 2 F
diseases Acute lymphoblastic leukaemia 17 M
Acute lymphoblastic leukaemia 18 M
Acute myeloblastic leukaemia 1 M
Hodgkin’s disease 14 F
Non-Hodgkin’s lymphoma (clinical
diagnosis)
14 M
Non-Hodgkin’s lymphoma 5 M
CNS tumours Brain, undefined malignant tumour
(clinical diagnosis)
7M
Brain, undefined malignant tumour
(clinical diagnosis)
18 M
Cerebellar astrocytoma 8 F
Cerebellar medulloblastoma 2 M
Cerebellar medulloblastoma 8 F
Neurilemmoma (Schwannoma) 8 F
Sarcomas Mesenchymal chondrosarcoma 16 F
Rhabdomyosarcoma 1 M
Renal tumours Wilm’s tumour 6 M
Testicular tumours Malignant teratoma 15 M
Teratocarcinoma 17 M
Ovarian tumours Androblastoma 5 F
Neuroendocrinal
tumours
Neuroendocrine carcinoma 17 F
aM¼male, F¼female.
Table 2 Observed (obs) and expected (exp) numbers and SIRs for all
and selected types of cancer in children of women with a molar pregnancy,
followed-up in childhood and adolescence
Primary cancer of child Obs Exp SIR
a 95% CI
a
All cancers 20 14.3 1.40 0.86–2.16
Haematological diseases 7 5.4 1.30 0.52–2.68
Leukaemias 4 3.9 1.02 0.27–2.61
CNS tumours 6 4.6 1.32 0.48–2.88
Sarcomas 2 1.7 1.17 0.14–4.22
Testicular cancer 2 0.5 4.41 0.53–15.9
aCI¼confidence interval; SIR¼standardised incidence ratios.
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